RecruitingNCT03827694
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Studying Aspergillosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Arkansas Children's Hospital Research Institute
- Principal Investigator
- William Steinbach, D.CUniversity of Arkansas
- Intervention
- Non-Invasive Testing for PIFI(diagnostic_test)
- Enrollment
- 400 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2018 – 2026
Study locations (30)
- Arkansas Children's Research Institute, Little Rock, Arkansas, United States
- Rady Children's Hospital, UCSD, La Jolla, California, United States
- Children's Hospital of Orange County, Orange, California, United States
- Lucile Packard Children's Hospital, Stanford University, Palo Alto, California, United States
- University of California San Francisco, Benioff Children's Hospital, San Francisco, California, United States
- Yale University, New Haven, Connecticut, United States
- Children's National Hospital, Washington D.C., District of Columbia, United States
- All Children's Research Institute, St. Petersburg, Florida, United States
- Emory University-Children's Healthcare of Atlanta (CHOA), Atlanta, Georgia, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- University of Chicago Medicine, Comer Children's, Chicago, Illinois, United States
- Indiana University School of Medicine, Indianapolis, Indiana, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- University of Minnesota Medical School, Minneapolis, Minnesota, United States
- Children's Minnesota, Saint Paul, Minnesota, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Children's Hospital of Philadelphia · National Institute of Allergy and Infectious Diseases (NIAID)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03827694 on ClinicalTrials.govOther trials for Aspergillosis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT07238114Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk FactorsUniversitaire Ziekenhuizen KU Leuven
- RECRUITINGPHASE2NCT06794554Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment OptionsMundipharma Research Limited
- RECRUITINGNCT07313527PCR for Aspergillus Fumigatus in Blood and Bronchoalveolar Lavage Fluid for Monitoring Cases of Invasive Aspergillosis: What is Its Prognostic ValueUniversity Hospital, Strasbourg, France
- ACTIVE NOT RECRUITINGNCT06583512Treatment Duration of IPAPeking University People's Hospital
- RECRUITINGNCT06885905Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-beingImperial College London
- RECRUITINGNANCT06440915Study on Theraputic Drug Monitoring and Phamacokinetics of Isavuconazole in ChildrenShanghai Children's Medical Center
- RECRUITINGPHASE3NCT06447402A Trial to Compare Nebulized Amphotericin B and Nebulized Normal Saline as Maintenance in Patients With Chronic Pulmonary AspergillosisPost Graduate Institute of Medical Education and Research, Chandigarh
- RECRUITINGPHASE2NCT05653193Interferon-gamma as Adjunctive Therapy in Chronic Pulmonary Aspergillosis: a Randomised Feasibility StudyManchester University NHS Foundation Trust